鶹ýƵվ

XClose

Convince Hemodiafiltration Dialysis 鶹ýƵվ

Home
Menu

Publications

Publications
It was agreed that any research that CONVINCE generates is based on a prior consensus of all members of the CONVINCE Scientific Committee.

Gregor Liegl, Felix H. Fischer, Bernard Canaud, Mark Woodward, Claudia Barth, Andrew Davenport,Marietta Török, Giovanni F. M. Strippoli, Jörgen Hegbrant, Krister Cromm, Michiel L. Bots,Peter J. Blankestijn, Kathrin I. Fischer, Matthias Rose on behalf of the CONVINCE Scientific Committee. Using a measurement type‑independent metric to compare patterns of determinants between patient‑reported versus performance‑based physical function in hemodialysis patients. Quality of Life Research 2024

Matthias Rose, Felix H. Fischer, Gregor Liegl, Giovanni FM. Strippoli, Carina Hockham, Robin WM. Vernooij, Claudia Barth, Bernard Canaud, Adrian Covic, Krister Cromm, Andrea M. Cucui, Andrew Davenport, Kathrin I. Fischer, Jörgen Hegbrant, Hanna Jaha, Anna Schappert, Marietta Török, Mark Woodward, Michiel L. Bots, Peter J. Blankestijn, for the CONVINCE Scientific Committee and CONVINCE Investigators.The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration. Kidney International2024 Jul 30:S0085-2538(24)00534-9.

Vernooij RWM, Hockham, C, Barth C, Canaud B, Cromm K, Davenport A, Hegbrant J, Rose M, Strippoli GFM, TörökM, Woodward M, Bots ML, Blankestijn PJ.;High-target haemodiafiltration convective dose achieved in the majority of patients in a 6-month intermediary analysis of the CONVINCE randomised controlled trial. Kidney International Reports 2023 Vol 8(11) p. 2276-2283.

Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli G, Canaud B, Hegbrant J, Barth C, Covic A, Cromm K, Cucui A, Davenport A, Rose M,TörökM, Woodward M, Bots MLfor theCONVINCE Scientific Committee Investigators. Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. New England Journal of Medicine 2023, 389 p.700-709

Liegl G, Fischer FH, Woodward M, Török M, Strippoli GFM, Hegbrant J, Davenport A, Cromm K, Canaud B, Bots ML, Blankestijn PJ, Barth C, Fischer KI, Rose M; CONVINCE Scientific Committee. Physical Performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis. J. Clin Epidemiol. 2023 Vol 159, p. 128-138.

van Kruijsdijk RCM, VernooijRWM, Bots ML,PetersSAE, Dorresteijn JAN, VisserenFLJ,Blankestijn PJ, Debray,TPA,The HDF Pooling Project investigators. Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction,Clinical Kidney Journal 2022; 15(10); 1924-1931.

VernooijRWM, BotsML, Strippoli GFM, Canaud B, Cromm K, Woodward M, Blankestijn, PJNephrol Dial Transplant 2022 37(6): 1006-1013. doi: .

Davenport A.. Gerontol Geriatr Med. 2022 Mar 28;8:23337214221085875. doi: eCollection 2022 Jan-Dec.

BlankestijnPJ,FischerKI, BarthC, Cromm K, CanaudB, Davenport A, Grobbee DE, Hegbrant J, Roes KC, RoseM, Strippoli GF, Vernooij RW, Woodward M, de Wit GA, Bots ML.BMJ OPEN, 2020, 10 (2), doi:10.1136/bmjopen-2019-033228

Blankestijn PJ, Grooteman MP,Nube MJand Bots ML. . Nephrology Dialysis Transplantation 2018, 33, iii53-iii58. doi: 10.1093/ndt/gfy218.

Meeting Presentations

Kathrin I. Fischer, Peter J. Blankestijn, Krister Cromm, Michiel L. Bots, Claudia Barth, Bernard Canaud, Jörgen Hegbrant, Giovanni Strippoli, Andrew Davenport, Mark Woodward, Matthias Rose on behalf of the CONVINCE Consortium.Assessing the Patient’s Perspective in End-stage Kidney Disease –ADomain-Guided Approach Applied in the CONVINCE Trial. Poster presentation at 26th Annual Conference ISOQOL, 2019.

Fischer KI, Blankestijn PJ, Cromm K, Bots ML, Barth C, Canaud B, Hegbrant J, Macário F, Marrón B, Török M, Davenport A, Lee MM, Strippoli GFM, Wohn L, Woodward M, Rose M. Assessment of generic and dialysis-related fatigue – Identification of individual trajectories and investigation of ecological validity. Quality of Life Research. 2020;29(S1): S180. link to abstract. Poster presentation at 27th Annual Conference ISOQOL, 2020.

Robin W.M. Vernooij, on behalf of the CONVINCE 鶹ýƵվ Group “The comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) study” presentation at the 58th ERA-EDTA Congress in Berlin, June 2021. Nephrology Dialysis Transplantation, Volume 36, Issue Supplement_1, May 2021, gfab098.004,

Gregor Liegl, Felix H. Fischer, Peter J. Blankestijn, Krister Cromm, Michiel L. Bots, Matthias Rose, on behalf of the CONVINCE Scientific Committee, Can patient-reported and performance outcome measures be used to assess a common construct of general physical function in patients undergoing hemodialysis? Oral presentation at the ISOQOL 2022 Prague.

Le Hong Ngoc Pham, Krister Cromm, Yan Zhang, Anna Schappert, Gregor Liegl, Kathrin I. Fischer, Felix Fischer and Matthias Rose. Psychometric validation of the CONVINCE inter- & intradialytic symptoms questionnaire. American Society of Nephrology Accepted as poster presentation at the 56th Annual Meeting of the American Society of Nephrology in Pennsylvania USA 1-5 November 2023.

Krister Cromm, Le Hong Ngoc Pham, Hanna Jaha, Anna Schappert, Gregor Liegl, Kathrin I. Fischer, Felix Fischer, Matthias Rose. Self-Efficacy and Social Support Determine Self-Reported Health in hemodialysis patients. Accepted as oral presentation at the 56th Annual Meeting of the American Society of Nephrology in Pennsylvania USA 1-5 November 2023.

Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Barth C, Canaud B, Covic A, Cromm K, Cucui AM, Davenport A, Hegbrant J, Rose M, Sanchez Torres D, Török M, Woodward M, Bots ML, for the CONVINCE Scientific Committee and CONVINCE Investigators. CONVINCE: Haemodiafiltration versus haemodialysis for mortality, cardiovascular events, and hospitalisation in adult patients. ERA 2023.

Krister Cromm, Le Hong Ngoc Pham, Hanna Jaha, Anna Schappert, Gregor Liegl, Felix Fischer, Matthias Rose. Self-Efficacy Explains Health-Related Quality of Life on Dialysis more than Social Support, Medical and Demographic Patient Characteristics. ISOQOL 2023, Calgary, Canada.